Liu et al.
(4R,5S,6S)-6-[(40-Methoxyphenoxy)methyl]-3-dodecyl-5,6-di-
JOCFeatured Article
(2S,3S,4R)-1-(40-Methoxyphenoxy)-3,4-bis(benzyloxy)octadec-
5-yn-2-amine (20). To a solution of 19 (23 mg, 37 μmol) in MeOH
(1 mL) were added Et3N (102 μL, 0.73 mmol) and 1,3-dithiopro-
pane (73 μL, 0.73 mmol). The reaction mixture was stirred over-
nightat50°C. The white precipitate was removed by filtration and
washed twice with MeOH. After the solvent was evaporated, the
residue was dried under high vacuum (0.2 Torr, overnight) and
used directly in the subsequent MTPA ester analysis without
further purification.
hydro-4H-pyrrolo[1,2-c][1,2,3]triazole-4,5-diol (14). A solution
of 20 mg (45 μmol) of diol 3 in 2 mL of toluene was stirred at
90 °C for 48 h. The solvent was evaporated, and the residue was
purified by column chromatography (elution with hexane/
EtOAc 1:1 to 2:3) to provide 14 (19 mg, 95%): [R]25 -20.8
D
(c 0.48, MeOH); 1H NMR (500 MHz, CDCl3) δ 0.88 (t, J = 7.0
Hz, 3H), 1.19-1.39 (m, 16H), 1.53-1.65 (m, 4H), 1.66-1.75 (m,
2H), 2.71 (t, J = 7.7 Hz, 2H), 3.75 (s, 3H), 4.42-4.46 (m, 1H),
4.48-4.53 (m, 1H), 4.73 (q, J = 3.4 Hz, 1H), 4.96-4.99 (m, 1H),
5.21 (d, J = 5.5 Hz, 1H), 6.72-6.80 (m, 4H); 13C NMR (100
MHz, CDCl3) δ 14.1, 22.7, 25.4, 29.1, 29.4, 29.62, 29.65, 29.68,
31.9, 55.7, 64.5, 64.8, 66.9, 77.9, 114.7, 115.9, 137.8, 143.3, 152.0,
154.6; ESI-HRMS [M þ H]þ calcd for C25H40N3O4þ 446.3013,
found 446.3006.
(2S,3S,4R)-2-Azidooctadec-5-yne-1,3,4-triol (22). Diol 3 (75
mg, 0.17 mmol) was dissolved in 2.5 mL of CH3CN/H2O (4:1) at
rt, and CAN (461 mg, 0.84 mmol) was added. The mixture was
stirred at rt until completion of the reaction as monitored by
TLC (about 1 h) and diluted with CHCl3. The resulting solution
was washed with H2O and brine. The organic layer was dried
(Na2SO4) and concentrated. The residue was purified by flash
chromatography (hexane/EtOAc 3:2) to afford triol 22 (52 mg,
(4R,5S,6S)-6-[(40-Methoxyphenoxy)methyl]-3-dodecyl-5,6-di-
hydro-4H-pyrrolo[1,2-c][1,2,3]triazol-4,5-diyl Acetate (15). To a
solution of 10 mg (22 μmol) of 14 in 1 mL of CH2Cl2 was added
100 μL (717 μmol) of Et3N and 50 μL (530 μmol) of Ac2O. The
solution was stirred overnight at rt. After the solvent was
removed, the residue was further dried under high vacuum
(0.7 Torr) for 1 h, dissolved in a minimal amount of CH2Cl2,
and filtered through a pad of silica gel in a buret. The pad was
rinsed with 10 mL of hexane/EtOAc 4:1. Concentration gave
diacetate 15 (11 mg, 98%) as a colorless syrup: 1H NMR (500
MHz, CDCl3) δ 0.88 (t, J = 7.2 Hz, 3H), 1.20-1.37 (m, 18H),
1.61-1.70 (m, 2H), 2.13 (s, 3H), 2.14 (s, 3H), 2.73 (t, J = 7.7
Hz, 2H), 3.75 (s, 3H), 4.48 (dd, J = 2.7, 10.4 Hz, 1H), 4.59 (dd,
J = 3.0, 10.4 Hz, 1H), 4.87 (dt, J = 4.3, 2.9 Hz, 1H), 6.05 (dd,
J = 4.3, 5.7 Hz, 1H), 6.31 (d, J = 5.8 Hz, 1H), 6.73-6.81 (m,
4H); 13C NMR (125 MHz, CDCl3) δ 14.1, 20.4, 20.5, 22.7,
25.3, 29.2, 29.3, 29.4, 29.57, 29.62, 29.64, 29.7, 31.9, 55.6, 62.2,
64.6, 66.4, 76.8, 114.6, 116.1, 134.6, 143.7, 151.7, 154.7, 169.5,
169.6.
(4S,5S,6S)-6-[(40-Methoxyphenoxy)methyl]-3-dodecyl-5,6-di-
hydro-4H-pyrrolo[1,2-c][1,2,3]triazol-4,5-diyl Acetate (150). Com-
pound 150 was prepared from syn-5 (35% de) according to the
same sequence used to convert anti-5 to 15 and was contaminated
with15 (ratio of 150/ent-15 = 1.2:1): 1H NMR (500 MHz, CDCl3)
δ 0.88 (t, J = 7.2 Hz, 3H), 1.20-1.37 (m, 18H), 1.61-1.70 (m,
2H), 2.14 (s, 3H), 2.15 (s, 3H), 2.69-2.72 (m, 2H), 3.76 (s, 3H),
4.51-4.53 (m, 2H), 4.72-4.75 (m, 1H), 5.85 (dd, J = 1.5, 1.9 Hz,
1H), 6.03 (d, J = 1.3 Hz, 1H), 6.73-6.81 (m, 4H); 13C NMR (100
MHz, CDCl3) δ 14.1, 20.4, 20.5, 22.7, 25.3, 29.2, 29.3, 29.4, 29.57,
29.62, 29.64, 29.7, 31.8, 55.6, 64.0, 67.0, 69.4, 84.3, 114.6, 115.8,
134.9, 143.6, 151.9, 154.5, 169.7, 169.8.
91%): [R]25 þ43.2 (c 0.5, MeOH); 1H NMR (500 MHz,
D
CD3OD) δ 0.90 (t, J = 7.1 Hz, 3H), 1.23-1.35 (m, 16H),
1.39-1.46 (m, 2H), 1.49-1.56 (m, 2H), 2.25 (dt, J = 2.0, 7.0
Hz, 2H), 3.52-3.57 (m, 2H), 3.69 (dd, J=7.2, 11.5 Hz, 1H),
3.96-4.00 (m, 1H), 4.45-4.47 (m, 1H); 13C NMR (100 MHz,
CDCl3) δ 14.1, 18.7, 22.7, 28.5, 28.9, 29.1, 29.3, 29.5, 29.62,
29.65, 31.9, 62.7, 63.9, 64.2, 73.7, 76.2, 89.3; ESI-HRMS [M þ
Na]þ calcd for C18H33N3O3Naþ 362.2414, found 362.2412.
D-ribo-Phytosphingosine (1). To a solution of 34 mg (0.10
mmol) of triol 22 in 5 mL of MeOH was added 11 mg (0.020
mmol) of 20% Pd(OH)2/C. The resulting suspension was de-
gassed three times and was stirred with a balloon filled with H2
overnight. The crude reaction mixture was filtered through a
short pad of Celite, which was washed with 30 mL of MeOH.
The combined filtrates were concentrated and purified by flash
chromatography (CHCl3/MeOH/concd NH4OH 130:25:4) to
afford 1 (20 mg, 63%) as a white solid. The product was
dissolved in a minimum volume of CHCl3 and passed through
a 0.45-μm filter to remove the suspended silica gel: mp 99-
101 °C (lit.9 mp 98.5-101.5 °C); [R]25D þ8.0 (c 0.8, C5H5N) [lit.9
[R]25 þ7.3 (c 0.9, C5H5N)]; H NMR (500 MHz, CD3OD) δ
1
D
0.89 (t, J = 7.1 Hz, 3H), 1.22-1.41 (m, 24H), 1.49-1.60 (m,
1H), 1.68-1.77 (m, 1H), 2.94-2.97 (m, 1H), 3.33 (dd, J= 5.4,
7.8 Hz, 1H), 3.47-3.52 (m, 1H), 3.55 (dd, J = 6.8, 10.9 Hz, 1H),
3.75 (dd, J = 4.1, 10.9 Hz, 1H); 13C NMR (125 MHz, CD3OD) δ
14.4, 23.8, 26.6, 30.5, 30.79, 30.82, 31.0, 33.1, 34.8, 55.8, 64.0,
þ
74.4, 76.4; ESI-HRMS [M þ Na]þ calcd for C18H39NNaO3
340.2822, found 340.2823.
D-ribo-Phytosphingosine Tetraacetate (23). Compound 23 was
prepared from 1 according to ref 9: [R]25D þ22.6 (c 0.7, CHCl3)
[lit.39 [R]20D þ21.9 (c 1.1, CHCl3)]; 1H NMR (500 MHz, CHCl3) δ
0.88 (t, J = 7.0 Hz, 3H), 1.16-1.39 (m, 24H), 1.57-1.72 (m, 2H),
2.03 (s, 1H), 2.05 (s, 6H), 2.09 (s, 3H), 4.00 (dd, J = 2.8, 11.7 Hz,
1H), 4.29 (dd, J = 4.7, 11.7 Hz, 1H), 4.44-4.51 (m, 1H), 4.93 (t,
J = 9.9, 2.8 Hz, 1H), 5.11 (dd, J = 2.8, 8.4 Hz, 1H), 6.06 (d, J =
9.4 Hz, 1H); 13C NMR (125 MHz, CHCl3) δ 14.1, 20.75, 20.78,
21.1, 22.7, 23.3, 25.5, 28.0, 29.28, 29.34, 29.5, 29.57, 29.61, 29.64,
29.66, 31.9, 47.5, 62.8, 71.8, 73.0, 169.8, 170.1, 170.9, 171.2.
(2S,3S,4R)-2-Azido-3,4-bis(benzyloxy)octadec-5-yn-1-ol (4).
Compound 19 (546 mg, 0.872 mmol) was dissolved in 25 mL
of CH3CN/H2O (4:1) at rt, and CAN (2.39 g, 4.36 mmol) was
added. The mixture was stirred at rt until completion, as
monitored by TLC (about 1 h), and was then diluted with
CHCl3. The resulting solution was washed with H2O and brine.
The organic layer was dried (Na2SO4) and concentrated. The
residue was purified by flash chromatography (elution with
hexane/EtOAc 10:1 to 6:1) to afford 349 mg (77%) of alcohol
4 as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 0.88 (t, J = 7.1
(2S,3S,4R)-1-(40-Methoxyphenyl)-2-azido-3,4-benzyloxy-5-
octadecyne-1,3,4-triol (19). To a mixture of 222 mg (5.56 mmol)
of NaH (60%) and 620 mg (1.39 mol) of diol 3 in 10 mL of
freshly distilled THF were added 343 μL (6.95 mmol) of benzyl
bromide and 3 mg (8 μmol) of TBAI at rt. The mixture was
stirred at rt overnight and then was quenched with 5 mL of
MeOH. The reaction mixture was poured into a mixture of
ice and EtOAc. The organic layer was separated, washed with
aqueous 1 M HCl, water, saturated aqueous NaHCO3 solution,
and brine, and then dried (Na2SO4). The solvent was evapo-
rated, and the residue was purified by flash chromatography
(hexane/EtOAc 40:1) to afford 19 (546 mg, 63%) as a colorless
1
oil. H NMR (500 MHz, CDCl3) δ 0.88 (t, J = 7.1 Hz, 3H),
1.20-1.30 (m, 12H), 1.37-1.44 (m, 2H), 1.51-1.60 (m, 2H),
2.28 (dt, J = 1.6, 7.0 Hz, 2H), 3.77 (s, 3H), 3.82 (t, J = 4.9 Hz,
1H), 4.00-4.06 (m, 2H), 4.18-4.23 (m, 1H), 4.40-4.42 (m, 1H),
4.51 (d, J = 11.6 Hz, 1H), 4.65 (d, J = 11.4 Hz, 1H); 13C NMR
(100 MHz, CDCl3) δ 14.1, 18.9, 22.7, 28.6, 29.0, 29.2, 29.4,
29.55, 29.64, 29.66, 31.9, 55.7, 61.5, 68.3, 70.0, 70.8, 74.3, 75.6,
80.1, 89.1, 114.6, 115.6, 127.8, 128.0, 128.2, 128.3, 128.4, 137.6,
137.8, 152.5, 154.1; ESI-HRMS [M
C39H51N3O4Naþ 648.3772, found 648.3776.
þ
Na]þ calcd for
(39) Shirota, O.; Nakanishi, K.; Berova, N. Tetrahedron 1999, 55, 13643–
13658.
J. Org. Chem. Vol. 75, No. 13, 2010 4363